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Understanding disease has engrossed many curious
minds throughout history. Early experimentation set the
path leading to present-day investigative efforts that have
yielded remarkable progress in information, technology,
resources, and the evolution of biomedical research and
discovery. For more than 100 years, the American Soci-
ety for Investigative Pathology (ASIP) has centered its
efforts on advancing knowledge regarding the pathogen-
esis of disease. During this time, the landscape of
pathology has evolved to embrace multiple related dis-
ciplines with shared interests in investigations of disease.
Of import, investigative pathology is central to current
clinical and translational research efforts. Accordingly,
ASIP has continuously transitioned to meet the needs of
its scientific constituency.
Recently, ASIP completed a comprehensive long-range
planning process under the leadership of Steven Galli,
M.D., and Richard Lynch, M.D., both former presidents of
ASIP. The resulting long-range plan calls for enhanced ac-
tivities to sustain excellence in investigative pathology, often
in coordination with other established professional pathol-
ogy organizations. To accomplish these goals, the leader-
ship of ASIP approved revisions to the Society mission to
reflect contemporary investigative pathology:
The mission of the Society is to promote the discovery,
advancement, and dissemination of basic and translational
knowledge in experimental pathology and related disci-
plines. This shall be achieved by fostering investigation
into the pathogenesis, classification, diagnosis, and man-
ifestations of disease through meetings, publications, and
educational activities.
Such breadth better reflects the purpose of the Soci-
ety, namely to foster the acquisition and dissemination of
knowledge regarding mechanisms of disease. The Amer-
ican Journal of Pathology, as an established keystone of
ASIP, fits squarely into this purpose by sustaining the
discipline of investigative pathology through its publica-
tion. The AJP supports the mission of ASIP with its own
well-developed and extensive scope:
AJP seeks to publish high-quality, original papers on the
cellular and molecular biology of disease. The editors ac-
cept manuscripts that advance basic and translational
knowledge of the pathogenesis, classification, diagnosis,
and mechanisms of disease, without preference for a spe-
cific analytic method. High priority is given to studies on
human disease and relevant experimental models using
cellular, molecular, animal, biological, chemical, and im-
munological approaches in conjunction with morphology.
These two objectives, the ASIP mission and AJP scope,
align to encompass the expertise and investigative interests
of the ASIP membership and support an integrated, multi-
disciplinary approach to further the study of disease.
The ASIP leadership, both elected and appointed,
shares common visions embodied in the ASIP mission.
The annual election of leaders seeks to invigorate the
membership and to achieve established goals. In addi-
tion, two ASIP appointments are particularly critical to
sustaining the activities of the Society: the ASIP Executive
Officer and the AJP Editor-in-Chief. As Executive Officer
since 2001, Mark E. Sobel, M.D., Ph.D., guides ASIP
operations and ensures that the objectives of the Society
are achieved. Another key ASIP appointment rests in the
AJP Editor-in-Chief. Michael P. Lisanti, M.D., Ph.D., who
has recently taken command of AJP, possesses research
interests and visions for the future of AJP that mirror the
multidimensional range of the AJP readers and authors
and the ASIP membership, as reflected in his recent
editorial.1 Thus, collectively, the ASIP leadership is in close
touch with the excitement and adventure of experimentation
and scientific discovery held by its membership toward
improving our understanding of human disease.
With a clear mission, enthusiastic leadership, and a
membership dedicated to the interdisciplinary study of
disease, the ASIP continues to explore the means to
assist investigators who share a common purpose: ex-
perimental studies to reveal the mysteries of disease.
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